Dagar V, Babbal , Mohanty S, Khasa Y
3 Biotech. 2022; 12(9):221.
PMID: 35971333
PMC: 9374863.
DOI: 10.1007/s13205-022-03293-1.
Cho J, Oh H, Jang Y, Kim H, Kim A, Song J
Microbiologyopen. 2022; 11(3):e1300.
PMID: 35765186
PMC: 9178654.
DOI: 10.1002/mbo3.1300.
Pykhtina M, Miroshnichenko S, Romanov V, Grazhdantseva A, Kochneva G, Beklemishev A
Pharmaceuticals (Basel). 2021; 14(5).
PMID: 34068113
PMC: 8152757.
DOI: 10.3390/ph14050459.
Dagar V, Adivitiya , Devi N, Khasa Y
J Ind Microbiol Biotechnol. 2016; 43(10):1373-86.
PMID: 27514666
DOI: 10.1007/s10295-016-1816-9.
Lang Y, Zhang Y, Zhan L, Feng Z, Zhou X, Yu M
BMC Biotechnol. 2014; 14:64.
PMID: 25027604
PMC: 4118627.
DOI: 10.1186/1472-6750-14-64.
Ex vivo expansion of primitive hematopoietic cells for cellular therapies: An overview.
McAdams T, Sandstrom C, Miller W, Bender J, Papoutsakis E
Cytotechnology. 2012; 18(1-2):133-46.
PMID: 22358646
DOI: 10.1007/BF00744329.
Design of recombinant stem cell factor-macrophage colony stimulating factor fusion proteins and their biological activity in vitro.
Chen T, Yang J, Wang Y, Zhan C, Zang Y, Qin J
J Comput Aided Mol Des. 2005; 19(5):319-28.
PMID: 16184434
DOI: 10.1007/s10822-005-5686-x.
Biological activity of human granulocyte-macrophage colony stimulating factor is maintained in a fusion with seed glutelin peptide.
Sardana R, Alli Z, Dudani A, Tackaberry E, Panahi M, Narayanan M
Transgenic Res. 2002; 11(5):521-31.
PMID: 12437083
DOI: 10.1023/a:1020343501475.
Haemopoietic growth factors in paediatric oncology: a review of the literature.
Wagner L, Furman W
Paediatr Drugs. 2001; 3(3):195-217.
PMID: 11310717
DOI: 10.2165/00128072-200103030-00003.
Characterization of a bifunctional enzyme fusion of trehalose-6-phosphate synthetase and trehalose-6-phosphate phosphatase of Escherichia coli.
Seo H, Koo Y, Lim J, Song J, Kim C, Kim J
Appl Environ Microbiol. 2000; 66(6):2484-90.
PMID: 10831428
PMC: 110565.
DOI: 10.1128/AEM.66.6.2484-2490.2000.
Peripheral blood progenitor cell cycle kinetics following priming with pIXY321 in patients treated with the "ICE" regimen.
Murren J, Gollerkeri A, Anderson S, Lutzker S, Del Prete S, Zelterman D
Yale J Biol Med. 1999; 71(5):355-65.
PMID: 10527363
PMC: 2578930.
Preparation of a recombinant chimaera of insulin-like growth factor II and interleukin 3 with high proliferative potency for haemopoietic cells.
Difalco M, Congote L
Biochem J. 1997; 326 ( Pt 2):407-13.
PMID: 9291112
PMC: 1218685.
DOI: 10.1042/bj3260407.
Production of interleukin 1beta by human hematopoietic progenitor cells.
Watari K, Mayani H, Lee F, Dragowska W, Lansdorp P, Schrader J
J Clin Invest. 1996; 97(7):1666-74.
PMID: 8601632
PMC: 507231.
DOI: 10.1172/JCI118593.
A circularly permuted recombinant interleukin 4 toxin with increased activity.
Kreitman R, Puri R, Pastan I
Proc Natl Acad Sci U S A. 1994; 91(15):6889-93.
PMID: 8041715
PMC: 44303.
DOI: 10.1073/pnas.91.15.6889.
Expression of Thy-1 on human hematopoietic progenitor cells.
Craig W, Kay R, CUTLER R, Lansdorp P
J Exp Med. 1993; 177(5):1331-42.
PMID: 7683034
PMC: 2191025.
DOI: 10.1084/jem.177.5.1331.
c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3.
Hanazono Y, Chiba S, Sasaki K, Mano H, Miyajima A, Arai K
EMBO J. 1993; 12(4):1641-6.
PMID: 7682176
PMC: 413378.
DOI: 10.1002/j.1460-2075.1993.tb05809.x.
Retrovirus-mediated transfer of MHC class II cDNA into swine bone marrow cells.
LeGuern C, Shimada H, Emery D, Germana S, Shafer G, Sachs D
J Mol Med (Berl). 1995; 73(6):269-78.
PMID: 7583449
DOI: 10.1007/BF00231613.
Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow.
Lansdorp P, Dragowska W
J Exp Med. 1992; 175(6):1501-9.
PMID: 1375263
PMC: 2119250.
DOI: 10.1084/jem.175.6.1501.